| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Dezocine | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Pentazocine lactate (substance) | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Pentazocine hydrochloride | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Phenazocine hydrobromide | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Qualitative measurement of opiate agonist | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Alfentanil measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Alphaprodine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Anileridine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Codeine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dextromoramide measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Diamorphine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Mersalyl measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oxycodone measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Methylfentanyl measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Norfentanyl measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| 6-beta-Naltrexol measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| 6-Monoacetylmorphine measurement (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Moricizine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oxymorphone measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Paramethadione measurement (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Despropionylfentanyl measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Methadone, long acting metabolite measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oxycodeinone measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Opioid screening | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Methadone measurement, urine | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine morphine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Methadone measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine codeine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine opiate measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Serum morphine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfin 300 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 1 ml | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 2 ml | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 1 ml | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 2 ml | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| bensomorfanopioid | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dimethadione measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Opiate agonist-antagonist product | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Butorphanol product | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine product | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Nalbuphine product | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| nalbufinhydroklorid 20 mg/ml, injektionsvätska, lösning, ampull | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dextropropoxyphene (substance) | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dihydrocodeine (substance) | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Phenazocine (substance) | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dextromoramide (substance) | Is a | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Serum methadone level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine diamorphine level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oral fluid opiate level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oral fluid morphine level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Oral fluid methadone level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine methadone metabolite level (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing pentazocine (medicinal product) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Meperidine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dihydromorphinone measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Opiates | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Trimethadione measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Quantitative measurement of opiate agonist | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Nalorphine measurement (procedure) | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| mätning av dihydrokodeinon | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Morphine measurement, quantitative | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| screening och mätning av morfin | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing butorphanol (medicinal product) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing buprenorphine (medicinal product) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing nalbuphine (medicinal product) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Nalbuphine hydrochloride [central nervous system use] | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Nalbuphine hydrochloride [anesthesia] | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine 70micrograms/hour transdermal patch | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine 52.5micrograms/hour transdermal patch | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine 35micrograms/hour transdermal patch | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Buprenorphine hydrochloride + naloxone hydrochloride | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfin 35 mikrogram per timme, depåplåster | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfin 52,5 mikrogram per timme, depåplåster | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| buprenorfin 70 mikrogram per timme, depåplåster | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Pentazocine hydrochloride 25 mg oral tablet | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| nalbufinhydroklorid | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| paracetamol + pentazocinhydroklorid | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| naloxonhydroklorid + pentazocinhydroklorid | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| acetylsalicylsyra + pentazocinhydroklorid | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Dihydrocodeine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Urine dihydrocodeine measurement | Component | False | Opiate agonist-antagonist | Inferred relationship | Some |  | 
| Product containing buprenorphine and naloxone (medicinal product) | Has active ingredient | False | Opiate agonist-antagonist | Inferred relationship | Some |  |